| ¿µ¹® | amino acids | ÇÑ±Û | ¾Æ¹Ì³ë»ê |
|---|---|---|---|
| ¼³¸í | ¾Æ¹Ì³ë±â(£NH3)¿Í Ä«¸£º¹½Ç±â(£COOH)¸¦ °¡Áö°í ÀÖ´Â ¸ðµç À¯±â¹°Áú. ´Ü¹éÁúÀ» ÀÌ·ç´Â ±âº»´ÜÀ§°¡ µÈ´Ù. Áï ´Ü¹éÁúÀº ¾Æ¹Ì³ë»êÀÌ ¿¬°áµÇ¾î¼ ÀÌ·ç´Â °ÍÀÌ´Ù. ÀÎü¿¡¼´Â ¾Æ¹Ì³ë»êÀÌ ´Ü¹éÁúÀÇ ±âº»´ÜÀ§°¡ µÇ´Â °Í¿Ü¿¡ ½Å°æ¼¼Æ÷¿Í ½Å°æ¼¼Æ÷°¡ ¼·Î ¿¬¶ôÀ» ÁÖ°í ¹Þ´Âµ¥ ¾²ÀÌ´Â ½Å°æÀü´Þ¹°Áú·Î¼ÀÇ ¿ªÇÒµµ ÇÑ´Ù. »ç¶÷ÀÇ ´Ü¹éÁúÀº 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÈ´Ù. Áï »ç¶÷¿¡ ÀÖ¾î¼ ´Ü¹éÁúÀ» ÇÕ¼ºÇÏ´Â µ¥´Â 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀÌ ÇÊ¿äÇÏ´Ù. ¿©±â¿¡¼ 11°¡Áö´Â ÀÎü³»¿¡¼ Á÷Á¢ ÇÕ¼ºÇÒ ¼ö ÀÖÁö¸¸ ³ª¸ÓÁö 9°¡Áö´Â ÇÕ¼ºÇÒ ¼ö ¾ø°í ¹Ýµå½Ã À½½Ä¹°¿¡¼ ¼·ÃëÇØ¾ß ÇÑ´Ù. À̰ÍÀ» Çʼö¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. |
||
| VLCFA | Very Long Chain Fatty Acids |
|---|---|
| TFA | total fatty acids; transverse fascicular area; triangular fibrocartilage; trifluoroacetic acid |
| ET | educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e... |
| EFA | Epilepsy Foundation of America; essential fatty acid; extrafamily adoptee |
| EFAD | essential fatty acid deficiency |
| LCP | Long Chain Polyunsaturated fatty acids |
|---|---|
| LCFA | Long chain fatty acids |
| MCFA | Medium-chain fatty acids |
| MUFA | Monounsaturated fatty acids |
| SCFA | Short Chain Fatty Acids |
| fatty acids, essential | Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids. (12 Dec 1998) |
|---|
| essential fatty acid | <biochemistry> The three fatty acids required for growth in mammals, arachidonic, linolenic and linoleic acids. Only linoleic acid needs to be supplied in the diet, the other two can be made from it. (18 Nov 1997) |
|---|---|
| essential amino acids | Alpha-amino acids nutritionally required by an organism and which must be supplied in its diet (i.e., cannot be synthesised by the organism) either as free amino acid or in proteins. (05 Mar 2000) |
| monounsaturated fatty acids | A fatty acid chain with at least two empty spaces that could be hydrogenated (have a hydrogen atom added). Saturated (hydrogenated) fatty acids are a greater health risk for the development of atherosclerotic vascular disease. (27 Sep 1997) |
| saturated fatty acids | In eukaryotic membranes refers to stearic, palmitic and myristic acids, that are linear aliphatic chains with no double bonds. Prokaryotes have numerous branched chain saturated fatty acids. (18 Nov 1997) |
| omega 3 fatty acids | A class of fatty acids that have a double bond three carbons from the methyl moiety; reportedly, they play a role in lowering cholesterol and LDL levels. Synonym: omega-3 fatty acids. (05 Mar 2000) |
| fatty acids | Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated). (12 Dec 1998) |
| fatty acids, monounsaturated | Fatty acids which are unsaturated in only one position. (12 Dec 1998) |
| fatty acids, nonesterified | The fraction of plasma fatty acids that are not in the form of glycerol esters. They are also called free fatty acids, but this is a misnomer because they are transported complexed with albumin. (12 Dec 1998) |
| fatty acids, omega-3 | A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness. (12 Dec 1998) |
| fatty acids, unsaturated | Fatty acids containing one (monounsaturated) or multiple (polyunsaturated) double bonds. They predominate in most plant-derived fats. The number and position of each double bond can be specified, as in the systematic names, or the position of the double bond closest to the methyl group (omega) terminus can be specified to denote functional subdivisions of the overall group, e.g., omega-3 fatty acids. The numbers and positions of the double bonds have been linked to effects on plasma lipid, triglyceride, and cholesterol levels. (12 Dec 1998) |
| fatty acids, volatile | Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans. (12 Dec 1998) |
| benign essential tremor | A benign tremor inherited as a dominant character; it may be a rapid oscillation resembling that seen in thyrotoxicosis, a coarse tremor during rest and inhibited by a voluntary effort, or one which appears only upon movement. Synonym: benign essential tremor, familial tremor. (05 Mar 2000) |
| drugs, essential | Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3) (12 Dec 1998) |
| osteolysis, essential | Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (gorham disease), multicentric (hajdu-cheney syndrome, winchester syndrome), or carpal/tarsal. (12 Dec 1998) |
| Eagle's minimum essential medium | A tissue culture medium similar to Eagle's basal medium but with different amounts and a few exclusions (e.g., antibiotics and phenol red). (05 Mar 2000) |
Synonyms : Acids, Essential Fatty, Essential Fatty Acids
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|